Average bioequivalence of single 500 mg doses of two oral formulations of levofloxacin: a randomized, open-label, two-period crossover study in healthy adult Brazilian volunteers

• Main Authors: Eunice Kazue Kano (Author), Eunice Emiko Mori Koono (Author), Simone Grigoleto Schramm (Author), Cristina Helena dos Reis Serra (Author), Eduardo Abib Junior (Author), Renata Pereira (Author), Márcia Sayuri Takamatsu Freitas (Author), Maria Cristina Iecco (Author), Valentina Porta (Author)
• Format: Book
• Published: Universidade de São Paulo, 2015-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Average bioequivalence of two 500 mg levofloxacin formulations available in Brazil, Tavanic(c) (Sanofi-Aventis Farmacêutica Ltda, Brazil, reference product) and Levaquin(c) (Janssen-Cilag Farmacêutica Ltda, Brazil, test product) was evaluated by means of a randomized, open-label, 2-way crossover stu...